| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2081751 | Drug Discovery Today: Disease Mechanisms | 2012 | 5 Pages |
Abstract
Our studies indicate that expression of antioxidative stress enzymes is upregulated by Selective Estrogen Receptor Modulators (SERMs) in breast epithelial cell lines, providing protection against the genotoxic effects of estrogens and against estrogen-induced mammary tumorigenesis. This upregulation of antioxidative stress enzymes requires Estrogen Receptor beta (ERĪ²) and human homolog of Xenopus gene which Prevents Mitotic Catastrophe (hPMC2). Further studies indicate that hPMC2 has a functional exonuclease domain that is required for upregulation of antioxidative stress enzymes by SERMs and repair of estrogen-induced abasic sites.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Monica M. Montano, Nirmala Krishnamurthy, Smitha Sripathy,